![Breaking News: InMed Pharmaceuticals Files New Patent for INM901 in the Fight Against Neurodegenerative Diseases, Including Alzheimer’s](https://marketsgonewild.com/wp-content/uploads/2024/12/Breaking-News-InMed-Pharmaceuticals-Files-New-Patent-for-INM901-in-the-Fight-Against-Neurodegenerative-Diseases-Including-Alzheimers-600x360.jpg)
Breaking News: InMed Pharmaceuticals Files New Patent for INM901 in the Fight Against Neurodegenerative Diseases, Including Alzheimer’s
Welcome to the Future of Neurodegenerative Disease Treatment! Exciting News from InMed Pharmaceuticals Inc. InMed Pharmaceuticals Inc. (NASDAQ: INM) has recently made a groundbreaking announcement regarding their proprietary small molecule drug candidate, INM-901. This pharmaceutical company, based in Vancouver, British Columbia, is dedicated to developing innovative treatments for diseases with high unmet medical needs. On…